Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, shared an article by Carla Oliveira, et al. on X:
“Cowabunga!
Riding Breast Cancer’s Biggest Data’s Wave from Literature.
PET/CT study drops major knowledge: metabolic markers predict response & recurrence in BC!
Tumor & lymphoid parameters surfing the waves of precision medicine.”
Baseline [18F]FDG PET/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy.
Authors: Carla Oliveira, et al.
